课题基金 / 基金详情

EFFICACY OF IV MILRINONE IN PATIENTS WITH CONGESTIVE HEART FAILURE

EFFICACY OF IV MILRINONE IN PATIENTS WITH CONGESTIVE HEART FAILURE
静脉注射米力农对充血性心力衰竭患者的疗效
批准号:
6114174
负责人:
MICHAEL R. BRISTOW
金额:
$3.22万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MICHAEL R. BRISTOW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a prospective, baseline-controlled open label study in patients with NYHA Class II-IV CHF who are currently receiving beta-blocker therapy with carvedilol or metoprolol. The objective of this study is to investigate the efficacy and safety of intravenous milrinone when administered to patients with congestive heart failure who are being treated with long-term (> 3 months) beta-blocker therapy with carvedilol or metoprolol. This study will also serve as a pilot study to help determine the appropriate dosing of intravenous milrinone for a planned comparative study to dobutamine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7719425
  • 项目类别:
  • 资助金额:
    $0.12万
  • 财政年份:
    2008
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7604375
  • 项目类别:
  • 资助金额:
    $1.01万
  • 财政年份:
    2007
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7377772
  • 项目类别:
  • 资助金额:
    $2.69万
  • 财政年份:
    2006
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
BETA-BLOCKER EFFECT ON REMODELING AND GENE EXPRESSION
  • 批准号:
    7200533
  • 项目类别:
  • 资助金额:
    $2.06万
  • 财政年份:
    2005
  • 负责人:
    MICHAEL R. BRISTOW
  • 依托单位:
海外基金